BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetic drug interactions with cyclosporin (Part II). 1990

G C Yee, and T R McGuire
Department of Pharmacy Practice, College of Pharmacy, University of Florida, Gainesville.

Part I of this article, which appeared in the previous issue of the Journal, considered the potential mechanisms of drug interactions with cyclosporin, and divided the interacting drugs into 2 categories. Drugs that decrease cyclosporin concentrations (e.g. anti-convulsants, rifampicin, etc.) were dealt with first; the authors then moved on to consider the second category, those that increase cyclosporin concentration (macrolide antibiotics, azole antifungal drugs). Part II continues the survey of this category.

UI MeSH Term Description Entries
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G C Yee, and T R McGuire
Pharmacokinetic drug interactions with phenytoin (Part II).
February 1990, Clinical pharmacokinetics,
G C Yee, and T R McGuire
Pharmacokinetic drug interactions with phenytoin (Part I).
January 1990, Clinical pharmacokinetics,
G C Yee, and T R McGuire
Pharmacokinetic interactions with calcium channel antagonists (Part II).
December 1991, Clinical pharmacokinetics,
G C Yee, and T R McGuire
Drug interactions: part II.
June 1992, The Annals of pharmacotherapy,
G C Yee, and T R McGuire
Pharmacokinetic drug interactions. Part 3: Drugs P-Z.
May 1995, Die Pharmazie,
G C Yee, and T R McGuire
Pharmacokinetic drug interactions. Part 2: Drugs D-O.
April 1995, Die Pharmazie,
G C Yee, and T R McGuire
Pharmacokinetic drug interactions. Part 1: Drugs A-C.
March 1995, Die Pharmazie,
G C Yee, and T R McGuire
Pharmacokinetic interactions between theophylline and other medication (Part II).
February 1991, Clinical pharmacokinetics,
G C Yee, and T R McGuire
Drug-Drug Interactions (DDIs) in Psychiatric Practice, Part 3: Pharmacokinetic Considerations.
January 2019, Journal of psychiatric practice,
G C Yee, and T R McGuire
Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, Part II.
January 2003, Psychosomatics,
Copied contents to your clipboard!